Ledger.Open graph →
SEC Form D · filed October 24, 2025

Theriva Biologics, Inc

Offering
$13.1M
Sold
$13.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
ROCKVILLE, MD
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Steven A. Shallcross · Rockville, MDExec · DirectorJeffrey J. Kraws · Rockville, MDDirectorJeffrey J. Wolf · Rockville, MDDirectorJohn J. Monahan · Rockville, MDDirectorJohn R. Madden · Chapel Hill, NCDirectorSimon R. Whiteley · Cheshire, United KingdomDirectorJason Dempsey · Chapel Hill, NCDirectorEmma R. Bryant · Cheshire, United KingdomExec · DirectorDmitry Vinogradov · San Francisco, CAExec · DirectorAlexander Nevinskiy · Dover, DEDirectorGrigory Sapunov · San Francisco, CADirectorKonstantin Savenkov · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗